Skip to main content
SpringerLink
Log in

Competitive Dynamics in Pharmaceutical Markets: A Case Study in the Chronic Cardiac Disease Market

  • Chapter
  • First Online:
System Dynamics

Part of the book series: OR Essentials ((ORESS))

  • 2250 Accesses

Abstract

A modelling project involved system dynamics simulation of chronic cardiac disease in Bulgaria, examining the dynamic behaviour of a cardiac drug molecule in the market. The system dynamics model was calibrated using market data sourced from the Bulgarian National Health Care Fund, the Bulgarian Generic Pharmaceutical Association and a market research firm. The main results of the study showed that the timing of access to market was a critical driver in reducing prices and providing wider, as well as more affordable, access for patients to medicinal therapy. Our findings indicate that healthcare authorities may obtain savings while, at the same time, they may provide conditions for more patients to be treated depending on the timing of access to market of new generic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Arrow KJ (1963). Uncertainty and the welfare economics of medical care. America Economic Review 53(5): 951–954.

    Google Scholar 

  • Birch S, Kephart G, Tomblin-Murphy G, O’Brien-Pallas L, Alder R and MacKenzie A (2007). Human resources planning and the production of health: A needs-based analytical framework. Canadian Public Policy 33(Supplement 1): S1–S16.

    Article  Google Scholar 

  • Cooper K, Davies R, Raftery J and Roderick P (2008). Use of a coronary heart disease simulation model to evaluate the costs and effectiveness of drugs for the prevention of heart disease. Journal of the Operational Research Society 59(9): 1173–1181.

    Article  Google Scholar 

  • Dangerfield BC, Fang Y and Roberts C (2001). Model-based scenarios for the epidemiology of HIV/AIDS: The consequences of highly active antiretroviral therapy. System Dynamics Review 17(2): 119–150.

    Article  Google Scholar 

  • EC Pharmaceutical Forum Report. (2008). Working group on pricing and reimbursement. http://ec.europa.eu/pharmaforum/docs/ev_20081002_frep_en.pdf, accessed December 2011.

  • EGA Report. (2009). How to increase patient access to generic medicines in European healthcare systems. http://egagenerics.com/images/publication/PDF/Market_Barriers_Report_FINAL_ update.pdf

  • Folland, S., Goodman, A. and Stano, M. (2004). The Economics of Health and Health Care. New Jersey: Pearson Education, pp. 187–225.

    Google Scholar 

  • Generics Bulletin. (2011). Issues 5 August 2011 and 24 January 2011 www.generics-bulletin.com

  • Hirsch, G. (2004). Modeling the consequences of major incidents for health care systems. 22nd International Conference of the System Dynamics Society. Oxford, England, 25–29 July.

    Google Scholar 

  • Hirsch, G., & Immediato, C.S. (1998). Design of simulators to enhance learning: Examples from a health care microworld. International System Dynamics Conference. Quebec City, July.

    Google Scholar 

  • Hirsch, G. and Immediato, C. S. (1999). Microworlds and generic structures as resources for integrating care and improving health. System Dynamics Review 15(3): 16–25.

    Article  Google Scholar 

  • Hirsch, G., Homer, J., McDonnell, G., & Milstein, B. (2005). Achieving health care reform in the United States: Toward a whole-system understanding. 23rd International Conference of the System Dynamics Society. Boston, USA.

    Google Scholar 

  • Hoard, M., Homer, J., Manley, W., Furbee, P., Haque, A., & Helmkamp, J. (2005). Systems modeling in support of evidence- based disaster planning for rural areas. International Journal of Hygiene and Environmental Health 208(6): 117–125.

    Article  Google Scholar 

  • Homer J & Hirsch GB (2006). System dynamics modeling for public health: Background and opportunities. American Journal of Public Health 96(3): 452–458.

    Article  Google Scholar 

  • Homer, J., & Milstein, B. (2004). Optimal decision making in a dynamic model of poor community health. 37th Hawaii International Conference on System Science. Big Island, HI, 5–8 January.

    Google Scholar 

  • Homer J, Hirsch G, Minniti M and Pierson M (2004a). Models for collaboration: How system dynamics helped a community organize cost-effective care for chronic illness. System Dynamics Review 20(3): 199–222.

    Article  Google Scholar 

  • Homer, J., Jones, A., Seville, D., Essien, J., Milstein, B., & Murphy, D. (2004b). The CDC diabetes system modeling project: Developing a new tool for chronic disease prevention and control. 22nd International Conference of the System Dynamics Society. Oxford, England, 25–29 July.

    Google Scholar 

  • IMS Health Report. (2010). Generic Medicines: Essential contributors to the Long-term health of society. Sector sustainability challenges in Europe. http://egagenerics.com/images/publication/PDF/IMS.pdf

  • Jones AP, Homer JB, Murphy DL, Essien JDK, Milstein B and Seville DA (2006). Understanding diabetes population dynamics through simulation modeling and experimentation. American Journal of Public Health 96(3): 488–494.

    Article  Google Scholar 

  • Katsaliaki K and Mustafee N (2011). Applications of simulation within the healthcare context. Journal of the Operational Research Society 62(8): 1431–1451.

    Article  Google Scholar 

  • Kazakov R (2007a). Pricing and reimbursement policies in new EU accession countries. Journal of Generic Medicines 4(4): 249–258.

    Article  Google Scholar 

  • Kazakov R (2007b). Between strategy and change: Reformulating the medicines industry in an enlarged Europe. Journal of Medical Marketing 7(3): 245–253.

    Article  Google Scholar 

  • Kunc MH and Morecroft JD (2007). System dynamics modeling for strategic development. In F. O’Brien & R. Dyson (Eds.), Supporting strategy: Frameworks, methods and models. Chichester, UK: Wiley.

    Google Scholar 

  • Lane D, Monefeldt C and Rosenhead JV (2000). Looking in the wrong place for healthcare improvements: A system dynamics study of an accident and emergency department. Journal of the Operational Research Society 51(5): 518–531.

    Article  Google Scholar 

  • McDonnell, G., Heffernan, M., & Faulkner, A. (2004). Using system dynamics to analyse health system performance within the WHO framework. 22nd International Conference of the System Dynamics Society. Oxford, England, 25–29 July.

    Google Scholar 

  • McIntyre D, Thiede M and Birch S (2009). Access as a policy-relevant concept in low- and middle-income countries. Health Economics, Policy and Law 4(2): 179–193.

    Article  Google Scholar 

  • Milstein, B. (2008). Hygeia’s constellation: Navigating health futures in a dynamic and democratic world. The Center for Disease Control and Prevention. Syndemics Prevention Network, Archived version available at http://web.archive.org/web/20100307002849/http://www.cdc.gov/syndemics/monograph/index.htm, accessed 25 January 2013

  • Morecroft J (2007). Strategic Modelling and Business Dynamics: A Feedback Systems Approach. John Wiley and Sons: England.

    Google Scholar 

  • Murphy, G., et al. (2009). Tested solutions for eliminating Canada’s registered nurse shortage. Canadian Nurses Association www2.cna-aiic.ca/CAN, accessed 13 June 2012.

  • Roberts C and Dangerfield B (1990). Modelling the epidemiological consequences of HIV infection and AIDS: A contribution from operational research. Journal of the Operational Research Society 41(4): 273–289.

    Article  Google Scholar 

  • Roberts EB, Homer J, Kasabian A and Varrel M (1982). A systems view of the smoking problem: Perspective and limitations of the role of science in decision-making. International Journal of Biomedical Computing 13(1): 69–86.

    Article  Google Scholar 

  • Sterman JD (2000). Business dynamics. Systems thinking and modelling for a complex world. New York: McGraw-Hill.

    Google Scholar 

  • Stiglitz G (2003). Information and the change in the paradigm in economics. American Economist 47(2): 15–16.

    Article  Google Scholar 

  • Stiglitz JE and Jayadev A (2010). Medicine for tomorrow: Some alternative proposals to promote socially beneficial research and development in pharmaceuticals. Journal of Generic Medicines 7(3): 217–226.

    Article  Google Scholar 

  • Tengs TO, Osgood ND and Chen LL (2001). The cost-effectiveness of intensive national school-based anti-tobacco education: Results from the tobacco policy model. Preventive Medicine 33(6): 558–570.

    Article  Google Scholar 

  • Wolstenholme, E. F. (1996). A management flight simulator for community care. In S. Cropper & P. Forte (Eds.), Enhancing Decision Making in the NHS. Milton Keynes, UK: Open University Press.

    Google Scholar 

  • Wolstenholme EF (1999). A patient flow perspective of UK health services: Exploring the case for new ‘intermediate care’ initiatives. System Dynamics Review 15(3): 253–271.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Warwick Business School, University of Warwick, Coventry, UK

    M. Kunc

  2. BG PharmA, Sofia, Bulgaria

    R. Kazakov

Authors
  1. M. Kunc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Kazakov
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Warwick Business School, University of Warwick, Warwick, United Kingdom

    Martin Kunc

Copyright information

© 2018 The Author(s)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kunc, M., Kazakov, R. (2018). Competitive Dynamics in Pharmaceutical Markets: A Case Study in the Chronic Cardiac Disease Market. In: Kunc, M. (eds) System Dynamics. OR Essentials. Palgrave Macmillan, London. https://doi.org/10.1057/978-1-349-95257-1_15

Download citation

Publish with us

Policies and ethics

Search

Navigation